S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

This study is ongoing, but not recruiting participants.

Study NCT00243074 Information provided by Southwest Oncology Group

First Received: October 20, 2005 Last Updated: July 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2011 (Final data collection date for primary outcome measure)

Publications:

Garland LL, Chansky K, Wozniak A, et al.: SWOG S0509: A phase II study of novel oral antiangiogenic agent AZD2171 (NSC-732208) in malignant pleural mesothelioma. [Abstract] J Clin Oncol 27 (Suppl 15): A-7511, 2009.